Tag: Mosapride

Used widely in Japan, China, and several South American countries for gastrointestinal motility issues, mosapride is not approved for clinical use in the United States. For individuals suffering from gastroparesis or functional dyspepsia, understanding why **is mosapride available in the US** is a crucial first step in finding effective treatment within the U.S. healthcare system.

An estimated 15-20% of the global population suffers from Gastroesophageal Reflux Disease (GERD), a condition that can be treated with specific medications. Mosid, a brand name for the active ingredient Mosapride, is a prescription medication used to address the symptoms of GERD and other digestive motility disorders. It works by increasing stomach and intestinal movement, facilitating the faster passage of food through the digestive tract.